TAKEDA
TAKEDA PHARMACEUTICAL CO LTD
Quick answer
TAKEDA is a pharma company (TAK) headquartered in TOKYO, M0, USA with 24 tracked pipeline programs.
Pipeline (24)
25 mg Ontamalimab
Crohn's Disease
1 trials project9vHPV Vaccine
Dengue Fever
1 trials projectALX1-11
Osteoporosis
1 trials projectALX1-11 (drug)
Osteoporosis
1 trials projectAMG 479
Adenocarcinoma of the Pancreas
1 trials projectAMG 706
Non-Small Cell Lung Cancer
1 trials projectARALAST NP 60 mg/kg
Chronic Obstructive Pulmonary Disease
1 trials projectASCs (Cx401, company code)
Anal Fistula
1 trials projectActovegin
Post-Stroke Cognitive Impairment (PSCI)
1 trials projectActovegin
Peripheral Arterial Diseases
1 trials projectAdynovate
Hemophilia A
1 trials projectAlisertib
Relapsed Peripheral T-Cell Lymphoma
1 trials projectAlogliptin
Diabetes Mellitus
9 trials projectAlogliptin Benzoate
Diabetes Mellitus, Type 2
1 trials projectAlogliptin and glimepiride
Type 2 Diabetes Mellitus
2 trials projectAlogliptin and glyburide
Diabetes Mellitus
1 trials projectAlogliptin and insulin
Diabetes Mellitus
1 trials projectAlogliptin and metformin
Diabetes Mellitus
1 trials projectAlogliptin and metformin
Type 2 Diabetes Mellitus
1 trials projectAlogliptin and pioglitazone
Type 2 Diabetes Mellitus
2 trials projectAlogliptin and pioglitazone
Diabetes Mellitus
2 trials projectAlogliptin and voglibose
Type 2 Diabetes Mellitus
2 trials projectAmlodipine
Hypertension
1 trials projectAnagrelide Hydrochloride
Essential Thrombocythemia (ET)
1 trialsDrugs (12)
alogliptin benzoate
NESINA
drugamoxicillin
AMOXICILLIN AND CLAVULANATE POTASSIUM
druganagrelide hydrochloride
ANAGRELIDE HYDROCHLORIDE
drugbrigatinib
ALUNBRIG
drugcefotiam hydrochloride
CERADON
drugdexlansoprazole
DEXLANSOPRAZOLE
drugfruquintinib
FRUZAQLA
drugglimepiride
GLIMEPIRIDE
drugicatibant acetate
ICATIBANT ACETATE
drugixazomib citrate
NINLARO
druglansoprazole
LANSOPRAZOLE
druglanthanum carbonate
LANTHANUM CARBONATE
Patents (8)
US 12428403
N-(heterocyclyl and heterocyclylalkyl)-3-benzylpyridin-2-amine derivatives as SS
patentUS 12419890
Administration of sumo-activating enzyme inhibitor and checkpoint inhibitors
patentUS 12421188
Heterocyclic compound and use thereof
patentUS 12415866
Monoclonal antibody inhibitor of Factor XIIa
patentUS 12415782
Heterocyclic compound and use thereof
patentUS 12409210
CNS delivery of therapeutic agents
patentUS 12404237
Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biph
patentUS 12403154
Administration of sting agonist and checkpoint inhibitors